Indian Army Pharmaceutical Supply: Respiratory and Anti-Allergic Medications Procurement

This tender, bid number GEM/2026/B/8037092, issued by the Department of Military Affairs, Ministry of Defence, for the Indian Army, is seeking the supply of a comprehensive range of critical pharmaceutical products. The bid period commences on October 13, 2026, at 12:53 PM and concludes on October 24, 2026, at 1:00 PM. The scope of this tender encompasses a substantial total quantity of 56,275 units, with a detailed item category listing including various bronchodilators, anti-inflammatory agents, antihistamines, mucolytics, and respiratory inhalers. Specific medications required include, but are not limited to, Acebrophylline in various strengths (100mg, 200mg), Acetylcysteine (600mg), Asthalin Rotacaps, Beclomethasone Dipropionate (50mcgm, 200mcg MDI, 50mcgm), Bilastine (20mg dispersible tablets), Budesonide in respuled and MDI forms (0.5mg, 1mg, 100mcg, 200mcg, 400mcg), Fexofenadine (120mg), Fluticasone Furoate (27.5mcg nasal spray), Formoterol in combination with Budesonide (6mcg/100mcg, 6mcg/200mcg, 6mcg/400mcg) and Tiotropium (18mcg DPI), Guaiphen, Dextromethorphan, Phenylephrine, Chlorpheniramine, Orciprenaline (10mg), Pheniramine Maleate (25mg), Pirfenidone (200mg), Promethazine (25mg), Levosalbutamol in various respuled and rotacap forms (0.31mg, 0.63mg, 50mcg), Salbutamol (200mcg rotacaps, 100mcg/dose MDI, 4mg tablets), Salmeterol/Fluticasone propionate combinations (50/250 Accuhaler, 25/125 MDI, 50/250 MDI), Hydroxyzine (10mg, 25mg), Formoterol/Tiotropium MDI (Duova), Formoterol/Tiotropium/Ciclesonide MDI (Triohalet), as well as injectable forms of Pheniramine (22.75mg/ml), Etophylline/Theophylline/Levosalbutamol/Beclometasone (Aerocort Rotacaps), and Beclometasone. This procurement is vital for ensuring the continuous provision of essential respiratory and anti-allergic medications for military personnel.